RIO

Take This Into Account Before Investing in RIO

Rio Tinto Plc logged a -1.7% change during today's afternoon session, and is now trading at a price of $68.97 per share. The S&P 500 index moved -0.0%. RIO's trading volume is 2,769,298 compared to the stock's average volume of 2,838,460.

Rio Tinto Plc trades -20.72% away from its average analyst target price of $87.0 per share. The 3 analysts following the stock have set target prices ranging from $75.0 to $98.0, and on average have given Rio Tinto Plc a rating of buy.

Anyone interested in buying RIO should be aware of the facts below:

  • Rio Tinto Plc has moved -7.6% over the last year, and the S&P 500 logged a change of 19.9%

  • Based on its trailing earnings per share of 5.27, Rio Tinto Plc has a trailing 12 month Price to Earnings (P/E) ratio of 13.1 while the S&P 500 average is 15.97

  • RIO has a forward P/E ratio of 16.4 based on its forward 12 month price to earnings (EPS) of $4.21 per share

  • Its Price to Book (P/B) ratio is 2.17 compared to its sector average of 2.07

  • Rio Tinto Group engages in exploring, mining, and processing mineral resources worldwide.

  • Based in London, the company has 54,000 full time employees and a market cap of $111.91 Billion. Rio Tinto Plc currently returns an annual dividend yield of 5.7%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS